Clario Acquired by Thermo Fisher Scientific — Healthcare M&A

Thermo Fisher Scientific has completed the acquisition of Clario, a healthcare IT business in the United States. Clario provides clinical and healthcare data management capabilities that support analytics and workflow needs across life sciences and provider organizations. Thermo Fisher Scientific acquisitions in healthcare IT aim to expand digital health and data-driven solutions alongside its existing diagnostics and laboratory offerings. The strategic acquisition is classified as an other acquisition, with deal size undisclosed, and was completed from a shareholder group that included Nordic Capital, Novo Holdings A/S, Astorg Asset Management S A.R.L., Cinven Limited, and Partners Group Private Equity Limited.